StonvexLoading…
StonvexStonvexStonvexCore line items from NUE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q2 2026 2026-04-04 | Annual 2025 2025-12-31 | Q4 2025 2025-10-04 | Q3 2025 2025-07-05 |
|---|---|---|---|---|---|
Revenue | $10.20B | $9.50B | $32.49B | $24.81B | $16.29B |
Operating Income | Not available | $1.10B | $2.57B | $2.07B | $1.18B |
Net Income | Not available | $743.00M | $1.74B | $1.37B | $759.00M |
EPS (Diluted) | $4.17 | $3.23 | $7.52 | $5.88 | $3.26 |
Total Assets | Not available | $35.63B | $35.10B | $34.78B | $34.22B |
Total Liabilities | Not available | $13.09B | $12.98B | $12.85B | $12.72B |
Cash & Equivalents | Not available | $2.23B | $2.26B | $2.22B | $1.95B |
Free Cash Flow OCF − CapEx | Not available | $225.00M | $-188.00M | $-185.00M | $-717.00M |
Shares Outstanding | Not available | 229.30M | 231.00M | 231.40M | 231.90M |